CoChat

HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients

Open access
Tan, R.Y.C., Camat, M.D., Ng, M., Lim, T.H., Lim, A.S.T., Lim, K.H., Tan, I.B.H. · 2018 · Annals of Oncology
Cited by 18

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Brain metastases from colorectal cancer (CRC) are a rare but increasing event as patients survive longer. While HER2 gene amplification in breast cancer is well described and known to increase risk of brain metastases [1], information in CRC patients with brain metastases is lacking. A multi-centre phase II trial has shown that HER2-directed therapies are efficacious in HER2 positive (HER2+) stage IV CRC without brain metastases [2]. If HER2 is enriched in CRC patients with brain metastases, it may provide a possible therapeutic target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdy156

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 18

Metadata

Authors
Tan, R. Y. C., Camat, M. D., Ng, M., Lim, T. H., Lim, A. S. T., Lim, K. H., & Tan, I. B. H.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2018-07
Volume
29
Issue
7
Pages
1598-1599
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2806959744
Cited by
18
References
1
FWCI
0.51
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients. https://app.cochat.ai/papers/10.1093/annonc/mdy156
The paper
Tan, R. Y. C., Camat, M. D., Ng, M., Lim, T. H., Lim, A. S. T., Lim, K. H., & Tan, I. B. H. (2018). HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients. Annals of Oncology. https://doi.org/10.1093/annonc/mdy156

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.